Search Results
Viewing: 751-760 of 3170 | All
News
National Survey of Emergency Department Management of Self-Harm Highlights Successes, Room for Improvement
In a study published today in JAMA Psychiatry, researchers at Nationwide Children’s Hospital describe the results of a national survey to evaluate how frequently evidence-based management practices are used in EDs when treating patients who present for self-harm.
News
Nationwide Children's Hospital Researcher, Mark Peeples, PhD, Elected as AAAS Fellow
Mark Peeples, PhD, principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital, has been elected a Fellow in the American Association for the Advancement of Science (AAAS). Dr.
Article
Past Global Scholars
News
New Study Finds Increase in Exposures to Synthetic Tetrahydrocannabinols Among Young Children, Teens, and Adults
A sharp rise in exposures to synthetic cannabis products among youth — some leading to hospitalization — highlights the need for increased education around the dangers of exposure and increased focus on safe storage and packaging, according to pediatricians and researchers at Nationwide Children’s Hospital and the Central Ohio Poison Center.
Article
Services We Offer
We treat the full array of blood disorders, cancers, immune-deficiency disorders, bone marrow failure syndromes and inherited metabolic storage diseases.
Specialty
Jerry R. Mendell Center for Gene Therapy
The mission of the Jerry R. Mendell Center for Gene Therapy is to investigate and employ the use of gene- and cell-based therapeutics for prevention and treatment of human diseases.
News
New Study Finds High-Powered Magnets Lead to Hospitalizations and Life-Threatening Injuries in Children
A recent study led by researchers at the Center for Injury Research and Policy and Emergency Medicine at Nationwide Children’s Hospital along with 24 other children’s hospitals across the country looked at nearly 600 cases of high-powered magnet-related injuries in the three years after high-powered magnets re-entered the US market (2017 to 2019).
Article
Feng Lab Staff
Learn more about principal investigator Zongdi Feng PhD, and his dynamic team in the Feng Lab.
News
Nationwide Childrens Hospital Leads Effort for Gene Therapy Treatment for Duchenne Muscular Dystrophy
Sarepta Therapeutics announced yesterday that the FDA has granted accelerated approval for eteplirsen for the treatment of Duchenne muscular dystrophy (DMD). Nationwide Children's Hospital was the sole original site for the clinical study that resulted in this approval, led by Dr.